Nziavake Masimasi
Internal Medicine · Glen Burnie, MDNPI 1366457160
Payments from drug & device makers
Across 222 payments — averaging $14.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$418
- Johnson & Johnson$349
- Novo Nordisk$296
- Boehringer Ingelheim$229
- Sanofi-aventis U.S. LLC$186
- Astellas Pharma US Inc$182
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,15497%
- Education$1103%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 43 | $418 |
| Johnson & Johnson | 22 | $349 |
| Novo Nordisk | 22 | $296 |
| Boehringer Ingelheim | 18 | $229 |
| Sanofi-aventis U.S. LLC | 13 | $186 |
| Astellas Pharma US Inc | 7 | $182 |
| Pfizer | 13 | $182 |
| Amarin Pharma, Inc. | 11 | $178 |
| Lilly USA, LLC | 19 | $176 |
| AstraZeneca | 8 | $155 |
| Merck | 9 | $119 |
| Viiv Healthcare Company | 1 | $117 |
| Gilead | 2 | $109 |
| Phathom Pharmaceuticals, Inc. | 1 | $103 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $103 |
| Amgen | 6 | $86 |
| Arbor Pharmaceuticals, Inc. | 3 | $52 |
| Kowa Pharmaceuticals America, Inc. | 4 | $47 |
| GSK | 3 | $41 |
| Nestle Healthcare Nutrition Inc. | 2 | $30 |
| Eisai Inc. | 2 | $30 |
| OPKO Pharmaceuticals, LLC | 1 | $19 |
| Ossur Americas, Inc. | 1 | $18 |
| Novartis | 1 | $14 |
| IBSA Pharma Inc. | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,264 in reported general payments places this provider in the 85th percentile of 2,979 internal medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 50 | $195,600 |
| DovatoDolutegravir Sodium/Lamivudine | 30 | $88,608 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 25 | $88,025 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 20 | $76,033 |
| TivicayDolutegravir Sodium | 22 | $49,752 |
| OzempicSemaglutide | 28 | $29,234 |
| EliquisApixaban | 12 | $7,152 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 21 | $2,782 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,327 |
| Atorvastatin Calcium | 78 | $589 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $507 |
| Losartan Potassium | 48 | $478 |
| Omeprazole | 31 | $472 |
| Hydroxyzine Hcl | 34 | $387 |
| Pregabalin | 18 | $363 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya | $109 | $283,62575 claims |
| Viiv Healthcare CompanyDovato, Tivicay | $117 | $138,36052 claims |
| Novo NordiskOzempic | $296 | $29,23428 claims |
| PfizerEliquis | $182 | $7,15212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,979 internal medicine providers in Maryland.
Other internal medicine in Glen Burnie
- Shishir KhetanRockville$52.1M
- Steven GellerElkridge$15.1M
- Mary HowellHagerstown$6.2M
- Kristen MarroneBaltimore$5.6M
- Jonathan CohenRockville$5M
- Andrea ApoloBethesda$4.8M
- Peta-Gay Jackson BoothBaltimore$3.6M
- Rahul PatelRockville$2.8M
- Mark YarchoanBaltimore$2.4M
- Marianne MannHighland$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.